세계 양자선 치료 시스템 시장 예측(-2030년) : 제품 유형별, 유형별, 셋업별, 적응증별, 최종 사용자별, 지역별 분석

According to Stratistics MRC, the Global Proton Therapy Systems Market is growing at a CAGR of 15.6% during the forecast period. Proton therapy systems are advanced medical technologies designed for precise cancer treatment, offering enhanced therapeutic effectiveness and an improved quality of life for cancer patients. Proton therapy allows for precise dose conformity to the shape of the tumor, enabling higher radiation doses to be delivered to the cancer cells while sparing healthy tissues.

According to the WHO (World Health Organization), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.

Market Dynamics:

Driver:

Rising incidence of cancer

Proton therapy, as an advanced form of radiation therapy, offers several advantages in cancer treatment. It utilizes protons to precisely target tumours, delivering higher radiation doses while minimizing damage to surrounding healthy tissues. This targeted approach reduces the risk of side effects and long-term complications associated with conventional radiation therapy. Proton therapy, with its ability to provide precise and accurate radiation delivery, has gained recognition as a valuable treatment modality, which enhances market demand.

Restraint:

Limited accessibility

While proton therapy is an advanced and effective treatment modality, the availability and accessibility of proton therapy centers are limited compared to conventional radiation therapy facilities. The geographical distribution of proton therapy centers plays a role in limited accessibility. Moreover, patients residing in remote or rural areas may face significant challenges in accessing proton therapy due to the distance and lack of nearby facilities. Therefore, limited accessibility is a significant factor hampering market expansion.

Opportunity:

Technological advancements

Improved design and functionality of proton therapy machines, coupled with sophisticated treatment planning systems, enable healthcare providers to deliver highly targeted radiation doses. The integration of advanced imaging technologies enhances the accuracy of treatment delivery by providing real-time visualization of the tumor and surrounding healthy tissues. Furthermore, software innovations in treatment planning facilitate personalized and adaptive approaches, optimizing proton therapy for individual patient needs. Hence, these technological innovations accelerate market growth.

Threat:

Availability of alternative technologies

While proton therapy offers unique advantages, alternative technologies such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) have also advanced significantly, providing comparable treatment outcomes in certain cases. IMRT, a widely adopted radiation therapy technique, uses multiple beams of radiation that can be adjusted to deliver precise doses to the tumor while minimizing exposure to surrounding healthy tissues. The availability of alternative technologies poses a challenge to market expansion.

COVID-19 Impact

The proton therapy systems market has experienced significant impacts from the COVID-19 pandemic. The financial strain on healthcare budgets during the pandemic has influenced investment decisions, potentially slowing down the adoption of proton therapy systems. However, the pandemic has also prompted innovation and adaptation. Telehealth solutions have been increasingly employed for patient consultations and follow-ups. Awareness of the benefits of proton therapy, such as reduced treatment-related side effects, has grown, emphasizing the importance of advanced cancer treatment modalities.

The rotating proton therapy systems segment is expected to be the largest during the forecast period

The rotating proton therapy systems segment is estimated to hold the largest share. Rotating proton therapy systems utilize a gantry that can rotate around the patient, providing a three-dimensional approach to irradiating tumours from various angles. This dynamic rotation allows for more precise targeting of cancerous cells while minimizing exposure to healthy tissues. Moreover, the ability to deliver proton beams from multiple directions enables improved conformity to the shape of the tumor, making it particularly effective for complex and irregularly shaped tumours.

The beam delivery system segment is expected to have the highest CAGR during the forecast period

The beam delivery system segment is anticipated to have lucrative growth during the forecast period. This system is responsible for directing and controlling the delivery of high-energy proton beams from the proton accelerator to the tumor site within the patient's body. The proton beam's depth and intensity are shaped and modulated by a combination of components, such as energy modulation devices, magnets, and collimators. Furthermore, modern beam delivery systems often incorporate scanning or spot-scanning techniques, allowing for even greater precision by delivering proton beams spot by spot.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The increasing incidence of cancer, coupled with a growing awareness of the benefits of proton therapy, drives the adoption of these advanced systems. In the United States, the presence of renowned cancer treatment centers and research institutions fosters a climate of innovation and technology adoption, propelling the development and deployment of proton therapy solutions. Additionally, collaborations between academic institutions, healthcare organizations, and industry players contribute to research advancements and the dissemination of best practices in proton therapy.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. European countries, including Germany, France, the United Kingdom, and others, exhibit a strong demand for proton therapy systems, driven by a rising incidence of cancer and an increasing emphasis on innovative medical technologies. Moreover, the region boasts a network of leading cancer treatment centers and research institutions actively engaged in the development and application of advanced proton therapy solutions.

Key players in the market:

Some of the key players in the Proton Therapy Systems Market include Mitsubishi Electric Corporation, Mevion Medical Systems, Hitachi, Advanced Oncotherapy plc, Ion Beam Applications SA, IBA worldwide, Varian, Provision Healthcare and ProTom International.

Key Developments:

In April 2023, Mitsubishi Electric India CNC has announced partnership with SolidCAM, a global leader in innovative CAM software for CNC machines and distribution of related digital manufacturing solutions.

In August 2022, IBA, the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, announces it has signed a collaboration agreement with Apollo Hospitals Enterprise Ltd, to provide proton therapy training and education programs for IBA customers in Asia.

Product Types Covered:

• Nozzle and Image Viewers
• Accelerator
• Beam Transport System
• Patient Positioning System
• Beam Delivery System

Types Covered:

• Rotating Proton Therapy Systems
• Non-Rotating Proton Therapy Systems

Set-Ups Covered:

• Single Room Systems
• Multiple Room Systems

Indications Covered:

• Lung Cancer
• Gastro-Intestinal Cancer
• Breast Cancer
• Prostate Cancer
• Brain Cancer
• Head & Neck Cancer
• Paediatric Cancer
• Other Indications

End Users Covered:

• Hospitals
• Proton Therapy Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Proton Therapy Systems Market, By Product Type

• 5.1 Introduction
• 5.2 Nozzle and Image Viewers
• 5.3 Accelerator
• 5.4 Beam Transport System
• 5.5 Patient Positioning System
• 5.6 Beam Delivery System

6 Global Proton Therapy Systems Market, By Type

• 6.1 Introduction
• 6.2 Rotating Proton Therapy Systems
• 6.3 Non-Rotating Proton Therapy Systems

7 Global Proton Therapy Systems Market, By Set-Up

• 7.1 Introduction
• 7.2 Single Room Systems
• 7.3 Multiple Room Systems

8 Global Proton Therapy Systems Market, By Indication

• 8.1 Introduction
• 8.2 Lung Cancer
• 8.3 Gastro-Intestinal Cancer
• 8.4 Breast Cancer
• 8.5 Prostate Cancer
• 8.6 Brain Cancer
• 8.7 Head & Neck Cancer
• 8.8 Pediatric Cancer
• 8.9 Other Indications

9 Global Proton Therapy Systems Market, By End User

• 9.1 Introduction
• 9.2 Hospitals
• 9.3 Proton Therapy Centers
• 9.4 Other End Users

10 Global Proton Therapy Systems Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Mitsubishi Electric Corporation
• 12.2 Mevion Medical Systems
• 12.3 Hitachi
• 12.4 Advanced Oncotherapy plc
• 12.5 Ion Beam Applications SA
• 12.6 IBA worldwide
• 12.7 Varian
• 12.8 Provision Healthcare
• 12.9 ProTom International